Aliquots - Research Briefs

This new entry to the field works in the background to provide real-time risk assessments, with no manual inputs from health care providers required.

Reports from 193 hospitals were analyzed. It turns out that surgeons draw the most complaints.

The antibodies may have clinical benefit as antiviral drugs to treat potentially life-threatening infections in elderly and immunosuppressed patients.

A full understanding of retinal cell types and their functions could point to novel therapeutic targets for diseases that affect the visual system, such as glaucoma — a leading cause of blindness for people over age 60.

A new interactive tool presents information on noncoding RNA in extracellular vesicles — agents of cell-cell communication that may have a future in medical diagnosis and therapeutics.

Artificial intelligence programs outperformed doctors at answering typical patient questions — suggesting they could be used to write first-draft responses and help speed doctors’ work.

Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.